Your browser doesn't support javascript.
loading
Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.
Li, He; Reksten, Tove Ragna; Ice, John A; Kelly, Jennifer A; Adrianto, Indra; Rasmussen, Astrid; Wang, Shaofeng; He, Bo; Grundahl, Kiely M; Glenn, Stuart B; Miceli-Richard, Corinne; Bowman, Simon; Lester, Sue; Eriksson, Per; Eloranta, Maija-Leena; Brun, Johan G; Gøransson, Lasse G; Harboe, Erna; Guthridge, Joel M; Kaufman, Kenneth M; Kvarnström, Marika; Cunninghame Graham, Deborah S; Patel, Ketan; Adler, Adam J; Farris, A Darise; Brennan, Michael T; Chodosh, James; Gopalakrishnan, Rajaram; Weisman, Michael H; Venuturupalli, Swamy; Wallace, Daniel J; Hefner, Kimberly S; Houston, Glen D; Huang, Andrew J W; Hughes, Pamela J; Lewis, David M; Radfar, Lida; Vista, Evan S; Edgar, Contessa E; Rohrer, Michael D; Stone, Donald U; Vyse, Timothy J; Harley, John B; Gaffney, Patrick M; James, Judith A; Turner, Sean; Alevizos, Ilias; Anaya, Juan-Manuel; Rhodus, Nelson L; Segal, Barbara M.
Affiliation
  • Li H; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Reksten TR; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
  • Ice JA; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Kelly JA; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Adrianto I; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Rasmussen A; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Wang S; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • He B; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Grundahl KM; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Glenn SB; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Miceli-Richard C; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
  • Bowman S; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Lester S; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Eriksson P; Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, INSERM U1012, Le Kremlin Bicêtre, France.
  • Eloranta ML; Rheumatology Department, University Hospital Birmingham, Birmingham, United Kingdom.
  • Brun JG; The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
  • Gøransson LG; Department of Rheumatology, Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Harboe E; Department of Medical Sciences, Rheumatology, SciLIfeLab, Uppsala University, Uppsala, Sweden.
  • Guthridge JM; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Kaufman KM; Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.
  • Kvarnström M; Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Cunninghame Graham DS; Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Patel K; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Adler AJ; Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
  • Farris AD; US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, United States of America.
  • Brennan MT; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Chodosh J; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
  • Gopalakrishnan R; Division of Oral and Maxillofacial Surgery, Department of Developmental and Surgical Science, University of Minnesota School of Dentistry, Minneapolis, Minnesota, United States of America.
  • Weisman MH; Department of Oral and Maxillofacial Surgery, North Memorial Medical Center, Robbinsdale, Minnesota, United States of America.
  • Venuturupalli S; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Wallace DJ; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Hefner KS; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
  • Houston GD; Department of Oral Medicine, Carolinas Medical Center, Charlotte, North Carolina, United States of America.
  • Huang AJW; Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Hughes PJ; Division of Oral Pathology, Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, Minnesota, United States of America.
  • Lewis DM; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
  • Radfar L; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
  • Vista ES; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
  • Edgar CE; Hefner Eye Care and Optical Center, Oklahoma City, Oklahoma, United States of America.
  • Rohrer MD; Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, Oklahoma, United States of America.
  • Stone DU; Heartland Pathology Consultants, Edmond, Oklahoma, United States of America.
  • Vyse TJ; Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, Missouri, United States of America.
  • Harley JB; Division of Oral and Maxillofacial Surgery, Department of Developmental and Surgical Science, University of Minnesota School of Dentistry, Minneapolis, Minnesota, United States of America.
  • Gaffney PM; Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, Oklahoma, United States of America.
  • James JA; Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, Oklahoma, United States of America.
  • Turner S; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Alevizos I; University of Santo Tomas Hospital, Manila, The Philippines.
  • Anaya JM; The Biology Department, Oklahoma Baptist University, Oklahoma City, Oklahoma, United States of America.
  • Rhodus NL; Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, Minnesota, United States of America.
  • Segal BM; Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, United States of America.
PLoS Genet ; 13(6): e1006820, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28640813
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: 2',5'-Oligoadenylate Synthetase / Interferon Type I / Sjogren's Syndrome / Quantitative Trait Loci Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: PLoS Genet Journal subject: GENETICA Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: 2',5'-Oligoadenylate Synthetase / Interferon Type I / Sjogren's Syndrome / Quantitative Trait Loci Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: PLoS Genet Journal subject: GENETICA Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States